Literature DB >> 27156770

Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.

Bereket Mochona1, Xin Qi2, Suresh Euynni3, Donald Sikazwi4, Nelly Mateeva1, Karam F Soliman3.   

Abstract

Various 1,3,4-oxadiazole derivatives have been synthesized and their antiproliferative properties have been studied. The in vitro screening was performed against androgen dependent (LNCaP) and androgen independent (PC-3) prostate cancer cell lines. Most of the compounds showed promising activity. Among them, compounds 2d (IC50=0.22 and 1.3μM) and 2a (IC50=8.34 and 2,5μM) have shown significant activities on PC-3 and LNCaP cell lines respectively. To investigate the mechanism of cell death we performed cell apoptosis staining and cell cycle arrest assay on more sensitive PC-3 cell lines on 2d. The results demonstrated that 2d induced apoptosis and shifted the cells to the sub G0/G1 and S phase. Our study evidently identified the potency of compound 2d as potential anti-prostate cancer agent. Published by Elsevier Ltd.

Entities:  

Keywords:  1,3,4-Oxadiazole; Apoptosis; Azoles; Cell cycle; Prostate cancer

Mesh:

Substances:

Year:  2016        PMID: 27156770      PMCID: PMC4888807          DOI: 10.1016/j.bmcl.2016.04.058

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  Gaussian docking functions.

Authors:  Mark R McGann; Harold R Almond; Anthony Nicholls; J Andrew Grant; Frank K Brown
Journal:  Biopolymers       Date:  2003-01       Impact factor: 2.505

Review 2.  Overcoming persistent dependency on androgen signaling after progression to castration-resistant prostate cancer.

Authors:  Masuo Yamaoka; Takahito Hara; Masami Kusaka
Journal:  Clin Cancer Res       Date:  2010-07-20       Impact factor: 12.531

Review 3.  Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis.

Authors:  Howard I Scher; Charles L Sawyers
Journal:  J Clin Oncol       Date:  2005-11-10       Impact factor: 44.544

4.  Structural basis for antagonism and resistance of bicalutamide in prostate cancer.

Authors:  Casey E Bohl; Wenqing Gao; Duane D Miller; Charles E Bell; James T Dalton
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-15       Impact factor: 11.205

5.  Oxadiazoles in medicinal chemistry.

Authors:  Jonas Boström; Anders Hogner; Antonio Llinàs; Eric Wellner; Alleyn T Plowright
Journal:  J Med Chem       Date:  2012-01-13       Impact factor: 7.446

6.  Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

Authors:  Rebecca Siegel; Elizabeth Ward; Otis Brawley; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2011-06-17       Impact factor: 508.702

7.  Structural basis for accommodation of nonsteroidal ligands in the androgen receptor.

Authors:  Casey E Bohl; Duane D Miller; Jiyun Chen; Charles E Bell; James T Dalton
Journal:  J Biol Chem       Date:  2005-08-29       Impact factor: 5.157

8.  Synthesis, pharmacological activity and comparative QSAR modeling of 1,5-N,N'-substituted-2-(substituted naphthalenesulphonyl) glutamamides as possible anticancer agents.

Authors:  Amit Kumar Halder; Nilanjan Adhikary; Milan Kumar Maity; Tarun Jha
Journal:  Eur J Med Chem       Date:  2010-01-21       Impact factor: 6.514

9.  Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database.

Authors:  Paul C D Hawkins; A Geoffrey Skillman; Gregory L Warren; Benjamin A Ellingson; Matthew T Stahl
Journal:  J Chem Inf Model       Date:  2010-04-26       Impact factor: 4.956

10.  Synthesis, structures, photo- and electro-luminescent properties of novel oxadiazole-functionlized europium(III) benzamide complexes.

Authors:  Fuli Zhang; Yanhui Hou; Chenxia Du; Yangjie Wu
Journal:  Dalton Trans       Date:  2009-07-16       Impact factor: 4.390

View more
  1 in total

Review 1.  Groundbreaking Anticancer Activity of Highly Diversified Oxadiazole Scaffolds.

Authors:  Alessandra Benassi; Filippo Doria; Valentina Pirota
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.